Industry News
-
Allotera Therapeutics Raises Additional $35M to Advance Off-the-Shelf CAR-T Therapy for T-Cell Cancers
Jul 08 2026 -
Genespire Reports Preclinical Data Supporting Immune-Shielded Lentiviral Gene Therapy for MMA
Jul 08 2026 -
Engineered AAV5 Vectors Use Glymphatic Delivery to Target Human Glial Cells Across the Brain
Jul 08 2026 -
Glymphatic Delivery of Engineered AAV5 Vectors Enables Broad Brain Targeting of Human Glial Cells
Jul 08 2026 -
Epicrispr Completes Dose Escalation in First-in-Human AAV Gene Therapy Trial for FSHD
Jul 07 2026 -
FDA Clears IND for CoRegen’s CRISPR-Engineered Treg Cell Therapy in Advanced Solid Tumors
Jul 07 2026 -
MeiraGTx Secures Investment to Support Late-Stage AAV Gene Therapy Programs
Jul 07 2026 -
FDA Clears IND for AAV9/SUMF1 Gene Therapy in Multiple Sulfatase Deficiency
Jul 06 2026 -
Opus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 in Inherited Retinal Disease
Jul 06 2026